Moreover, our in-vitro assays revealed the efficacy of CCSC-derived DRibbles in inducing anti-tumor immune responses, as demonstrated by a significant greater cytolytic activity and higher percentages of IFN-γ+-producing CD8+ T-cells in the SD-DC vaccination group. This evidence concerns the gene CD8A and neoplasm.